Takeda Reports First Quarter FY2018 Results
• Strong start on underlying revenue and profitability led by Growth Drivers and Opex discipline

• Reported operating profit and EPS impacted by large transactions in Q1 FY2017: 106.3 billion yen one-time gain on the sale of Wako and 16.8 billion yen from the 2nd tranche of products sold to Teva JV. Operating profit excluding these items was +37.5%